Silexion Therapeutics’ Preclinical Cancer Candidate Shows Tumor Reduction For Pancreatic Cancer
Silexion Therapeutics Corp. SLXN+1.65%+ Free Alertsreleased data on Wednesday from orthotopic pancreatic cancer models demonstrating that subcutaneously administered SIL204 effectively reduces primary tumor growth and metastatic spread.
Japanese Drug Regulator Approves Genmab Cancer Drug For Patients With Advanced Cervical Cancer – Genmab (NASDAQ:GMAB) – Benzinga
Japan approves Tivdak, the first ADC for cervical cancer, after Phase 3 trial shows a 30% reduction in death risk vs. chemotherapy.
Telomir Pharmaceuticals Lead Drug Candidate Inhibits Tumor Growth In Aggressive Prostate Cancer Cells, Animal Study Shows
On Wednesday, Telomir Pharmaceuticals, Inc. TELO+3.88% + Free Alertsrevealed preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a prostate cancer animal model with aggressive cancer cells.
